| 000 | 01621 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250514214836.0 | ||
| 264 | 0 | _c20050311 | |
| 008 | 200503s 0 0 eng d | ||
| 022 | _a0146-0404 | ||
| 024 | 7 |
_a10.1167/iovs.04-0601 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGaudreault, Jacques | |
| 245 | 0 | 0 |
_aPreclinical pharmacokinetics of Ranibizumab (rhuFabV2) after a single intravitreal administration. _h[electronic resource] |
| 260 |
_bInvestigative ophthalmology & visual science _cFeb 2005 |
||
| 300 |
_a726-33 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xpharmacokinetics |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 |
_aAqueous Humor _xmetabolism |
| 650 | 0 | 4 | _aArea Under Curve |
| 650 | 0 | 4 | _aBiological Availability |
| 650 | 0 | 4 | _aDrug Evaluation, Preclinical |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHalf-Life |
| 650 | 0 | 4 |
_aImmunoglobulin Fab Fragments _ximmunology |
| 650 | 0 | 4 | _aInjections |
| 650 | 0 | 4 | _aMacaca fascicularis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aRanibizumab |
| 650 | 0 | 4 | _aRecombinant Fusion Proteins |
| 650 | 0 | 4 |
_aRetina _xmetabolism |
| 650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _ximmunology |
| 650 | 0 | 4 |
_aVitreous Body _xdrug effects |
| 700 | 1 | _aFei, David | |
| 700 | 1 | _aRusit, Jeriza | |
| 700 | 1 | _aSuboc, Pamela | |
| 700 | 1 | _aShiu, Vanessa | |
| 773 | 0 |
_tInvestigative ophthalmology & visual science _gvol. 46 _gno. 2 _gp. 726-33 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1167/iovs.04-0601 _zAvailable from publisher's website |
| 999 |
_c15349643 _d15349643 |
||